• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

区分止血与血栓形成以获得治疗益处。

Differentiating haemostasis from thrombosis for therapeutic benefit.

机构信息

Shaun P. Jackson, Australian Centre for Blood Diseases, Alfred Medical Research and Education Precinct (AMREP), 6th level Burnet Tower, 89 Commercial Rd, Melbourne, Victoria 3004, Australia, Tel.: +613 9903 0131, Fax: +613 9903 0228, E-mail:

出版信息

Thromb Haemost. 2013 Nov;110(5):859-67. doi: 10.1160/TH13-05-0379. Epub 2013 Aug 15.

DOI:10.1160/TH13-05-0379
PMID:23945664
Abstract

The central role of platelets in the formation of the primary haemostatic plug as well as in the development of arterial thrombosis is well defined. In general, the molecular events underpinning these processes are broadly similar. Whilst it has long been known that disturbances in blood flow, changes in platelet reactivity and enhanced coagulation reactions facilitate pathological thrombus formation, the precise details underlying these events remain incompletely understood. Intravital microscopy studies have highlighted the dynamic and heterogeneous nature of thrombus development and demonstrated that there are considerable spatiotemporal differences in the activation states of platelets within a forming thrombus. In this review we will consider the factors regulating the activation state of platelets in a developing thrombus and discuss how specific prothrombotic factors may influence this process, leading to excessive thrombus propagation. We will also discuss some potentially novel therapeutic approaches that may reduce excess thrombus development whilst minimising bleeding risk.

摘要

血小板在初级止血塞形成以及动脉血栓形成中的核心作用已得到明确界定。一般来说,这些过程的基础分子事件非常相似。尽管人们早就知道血流紊乱、血小板反应性改变和增强的凝血反应会促进病理性血栓形成,但这些事件背后的确切细节仍不完全清楚。活体显微镜研究强调了血栓形成的动态和异质性,并表明在形成中的血栓中,血小板的激活状态存在相当大的时空差异。在这篇综述中,我们将考虑调节形成中的血栓中血小板激活状态的因素,并讨论特定的促血栓形成因子如何影响这一过程,导致过度的血栓增殖。我们还将讨论一些潜在的新的治疗方法,这些方法可以在减少出血风险的同时减少过度的血栓形成。

相似文献

1
Differentiating haemostasis from thrombosis for therapeutic benefit.区分止血与血栓形成以获得治疗益处。
Thromb Haemost. 2013 Nov;110(5):859-67. doi: 10.1160/TH13-05-0379. Epub 2013 Aug 15.
2
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.血小板活化机制:需要新策略来预防血小板介导的动脉粥样硬化血栓形成。
Thromb Haemost. 2009 Aug;102(2):248-57. doi: 10.1160/TH09-03-0192.
3
Platelets and primary haemostasis.血小板与初级止血。
Thromb Res. 2012 Mar;129(3):220-4. doi: 10.1016/j.thromres.2011.11.036. Epub 2011 Dec 16.
4
Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.血小板生物学与动脉血栓形成疾病抗血小板治疗的相关性。
Clin Appl Thromb Hemost. 2011 Aug;17(4):371-80. doi: 10.1177/1076029610373366. Epub 2010 Jun 21.
5
Current state and novel approaches of antiplatelet therapy.抗血小板治疗的现状和新方法。
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1327-38. doi: 10.1161/ATVBAHA.114.303413. Epub 2015 Apr 2.
6
Platelets in atherothrombosis.动脉粥样硬化血栓形成中的血小板。
Mayo Clin Proc. 2006 Jan;81(1):59-68. doi: 10.4065/81.1.59.
7
Thrombosis in diabetes: a shear flow effect?糖尿病中的血栓形成:一种剪切流效应?
Clin Sci (Lond). 2017 Jun 15;131(12):1245-1260. doi: 10.1042/CS20160391.
8
Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets.超活化血小板:血栓调节剂、凝血酶生成剂及潜在的临床靶点。
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1747-52. doi: 10.1161/ATVBAHA.113.301790.
9
Molecular regulation of platelet-dependent thrombosis.血小板依赖性血栓形成的分子调控
Circulation. 2005 Oct 25;112(17):2725-34. doi: 10.1161/CIRCULATIONAHA.104.494468.
10
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.2型糖尿病中的血小板高反应性:抗血小板药物的作用
Diab Vasc Dis Res. 2008 Jun;5(2):138-44. doi: 10.3132/dvdr.2008.023.

引用本文的文献

1
Identification of physicochemical properties that modulate nanoparticle aggregation in blood.调节纳米颗粒在血液中聚集的物理化学性质的鉴定。
Beilstein J Nanotechnol. 2020 Apr 3;11:550-567. doi: 10.3762/bjnano.11.44. eCollection 2020.
2
Imaging Platelet Processes and Function-Current and Emerging Approaches for Imaging and .血小板过程和功能的成像——成像和 的当前和新兴方法。
Front Immunol. 2020 Jan 31;11:78. doi: 10.3389/fimmu.2020.00078. eCollection 2020.
3
A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis.
血小板中剪切依赖性的 NO-cGMP-cGKI 级联反应作为血栓形成的自动调节制动机制。
Nat Commun. 2018 Oct 16;9(1):4301. doi: 10.1038/s41467-018-06638-8.
4
Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.新型检测方法显示,冠心病患者的促凝血小板反应增强。
J Thromb Haemost. 2018 Jun;16(6):1198-1210. doi: 10.1111/jth.14008. Epub 2018 May 8.
5
Compression force sensing regulates integrin αβ adhesive function on diabetic platelets.压缩力传感调节糖尿病血小板上整合素αβ的黏附功能。
Nat Commun. 2018 Mar 14;9(1):1087. doi: 10.1038/s41467-018-03430-6.
6
Current and future antiplatelet therapies: emphasis on preserving haemostasis.当前和未来的抗血小板治疗:强调保持止血功能。
Nat Rev Cardiol. 2018 Mar;15(3):181-191. doi: 10.1038/nrcardio.2017.206. Epub 2018 Jan 3.
7
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks.ACT017的设计、开发与特性研究,ACT017是一种人源化Fab片段,可阻断血小板糖蛋白VI功能且不引发出血风险。
MAbs. 2017 Aug/Sep;9(6):945-958. doi: 10.1080/19420862.2017.1336592. Epub 2017 Jun 9.
8
Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者的抗血小板治疗组合与血栓形成倾向
Korean Circ J. 2017 May;47(3):366-376. doi: 10.4070/kcj.2016.0384. Epub 2017 May 25.
9
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.在高脂血症条件下,血小板CD36通过激活氧化还原传感器ERK5促进血栓形成。
Blood. 2017 May 25;129(21):2917-2927. doi: 10.1182/blood-2016-11-750133. Epub 2017 Mar 23.
10
Factors XI and XII as Targets for New Anticoagulants.作为新型抗凝剂靶点的因子XI和因子XII。
Front Med (Lausanne). 2017 Feb 24;4:19. doi: 10.3389/fmed.2017.00019. eCollection 2017.